Novateor Research Laboratories Limited is an Indian-listed personal care and healthcare company specializing in the development and commercialization of innovative oral hygiene solutions. Operating under the flagship brand **SmiloShine**, the company is transitioning from a research-led boutique firm into a diversified manufacturer with a growing footprint in international e-commerce and industrial services. ### Strategic Diversification & Corporate Evolution Historically focused on a single segment, Novateor has recently undergone a significant strategic pivot. In **September 2025**, the company restructured its **Memorandum of Association (MOA)** to expand its legal mandate. * **Core Oral Care:** Continued focus on "first-of-its-kind" **FDCA-approved** teeth whitening and hygiene products. * **Dental Equipment Trading:** A new vertical focused on importing and distributing dental instruments, consumables, and **digital/diagnostic tools**. * **Chemicals & Coatings:** Entry into the formulation and application of resins and paints, providing **waterproofing and protective treatments** for industrial and residential sectors. * **Pharma & Cosmetics:** Future expansion plans into broader healthcare and cosmetic categories following the shift to new manufacturing premises. ### Product Portfolio: The SmiloShine Ecosystem The company leverages its **Novateor Research Facility** to develop products that offer clinical advantages over traditional oral care. The portfolio is designed for both domestic and global markets. | Product Category | Key Products | Notable Features | | :--- | :--- | :--- | | **Teeth Whitening** | Strips (3 variants), Gels, Powders, and **Advance Whitening Serum** | First in India with **FDCA approval**; targets premium cosmetic segments. | | **Innovative Toothpaste** | **ChocoJoy**, **Sensitive Nitraguard** | **ChocoJoy** is India’s first chocolate-flavored toothpaste; **Nitraguard** uses specialized enamel-strengthening tech. | | **Mouthwashes** | Activated Charcoal Whitening, Kids variants | Kids range includes **Orange, Lemon Lime, and Strawberry** flavors. | | **Prosthetic Care** | **Aligner & Denture Cleaner & Whitener Foam** | Launched **Feb 2026**; targets the growing global aligner market. | | **Devices** | **Sonic Power Toothbrush** | Electric/battery-powered segment launched in **Aug 2023**. | ### Manufacturing Modernization & Operational Scale To support its growth trajectory, Novateor is upgrading its production capabilities to meet international standards. * **Sanand Facility:** The company is shifting operations to a modern plant in **GIDC, Sanand (Ahmedabad District)**. * **Automation:** The new facility is designed with **semi-automation** to reduce reliance on manual labor and significantly minimize **raw material wastage**. * **Distribution Strategy:** Management is prioritizing **e-commerce portals** (e.g., Amazon) over traditional distribution to bypass logistics constraints. In **July 2023**, the company successfully launched on **Amazon USA**, marking its entry into the North American market. ### Financial Performance & Capital Structure Novateor has demonstrated a recovery in profitability alongside aggressive capital raising to fund its expansion. **Three-Year Financial Summary:** | Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Total Income** | **₹ 2.78 Crore** | **₹ 1.69 Crore** | **₹ 1.26 Crore** | | **Profit / (Loss) After Tax** | **₹ 8.18 Lakhs** | **₹ 6.28 Lakhs** | **(₹ 3.67 Lakhs)** | | **Net Worth** | - | **₹ 8.76 Crore** | - | | **EPS** | - | **0.06** | - | **Capital Raising Activities:** * **Authorized Capital:** Increased from **₹ 4.88 Crore** to **₹ 7 Crore** through late 2023 to accommodate growth. * **Warrant Conversion:** In **May 2025**, the company allotted **1,218,000 equity shares** at **₹ 28 per share** (including a **₹ 18 premium**) following the exercise of convertible warrants. * **IPO Amortization:** The company continues to amortize IPO expenses over **5 years**, with **₹ 1.49 Lakhs** remaining as of the last audit. ### Leadership & Governance The company has secured leadership stability with five-year re-appointments (effective **April 2024**) for: * **Mr. Navdeep Mehta:** Managing Director * **Mrs. Tejal Navdeep Mehta:** Whole Time Director * **Independent Directors:** Mr. Anand Rajendra Shah and Mr. Chintan Pankaj Shah (serving second terms). * **Remuneration:** Structured with a cap of **₹ 1.68 Crore** based on effective capital, ensuring leadership retention even during periods of fluctuating profits. ### Risk Profile & Audit Qualifications Investors should note persistent accounting deviations and market challenges that may impact valuation. **1. Regulatory & Accounting Non-Compliance:** Statutory auditors have issued **Qualified Conclusions** regarding several **Accounting Standards (AS)**: * **AS-2 (Inventory):** Valuation is based on **cost estimation** rather than technical valuation; the impact on P&L is unquantifiable. * **AS-15 (Employee Benefits):** No provision for **gratuity** has been made. Management cites a 10-year eligibility policy, which deviates from standard actuarial practices. * **AS-17 (Segment Reporting):** The company does not currently report separate divisional financial data. **2. Market & Operational Risks:** * **Competitive Pricing:** Intense pressure from local players in **India, China, and Brazil** who utilize e-commerce to offer discounted alternatives. * **Consumer Awareness:** As a pioneer in specialized whitening, the company faces high costs in educating the Indian market on "secondary" oral care products. * **Economic Sensitivity:** Vulnerability to **foreign exchange fluctuations** (due to imports/exports) and **raw material price volatility**. * **Liquidity:** While the company can meet short-term liabilities (within **one year**), auditors have noted no long-term guarantee of debt discharge.